Author's response to reviews Title: T/L-type calcium channel blocker reduces composite ranking for relative risk according to new KDIGO guidelines in patients with chronic kidney disease Authors:

T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease

BACKGROUND Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with chronic kidney disease (CKD) be assigned according to stage and composite relative risk on the basis of glomerular filtration rate (GFR) and albuminuria criteria. The aim of this post-hoc analysis was to investigate the effects of add-on therapy with calcium channel blockers (CCBs) on...

Author's response to reviews Title: Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study Authors:

The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines

BACKGROUND Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group recommended that patients with CKD should be assigned to stages and composite relative risk groups according to GFR (G) and proteinuria (A) criteria. Asians have among the highest rates of ESRD in the world, but establishing the prevalence and prognosis CKD is a problem for Asian populations since there is no conse...

Author's response to reviews Title: Predicting Hospital Cost in CKD Patients through Blood Chemistry Values Authors:

Author's response to reviews Title: The risk for chronic kidney disease in patients with heart diseases: a 7-year follow-up in a cohort study in Taiwan Authors: